Theodore Geh-Lu Liou MD

PubMed

• 1 citations
  Safety and extrapulmonary effects of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis following lung transplantation: A systematic review and meta-analy...
  Laura Venditto, Amber Neece, Federico Forgione, Ilaria Testa, Marta Da Pian
  Paediatric Respiratory Reviews. 2026-09-01
• Evaluation of Family History of Diabetes and the Development of Cystic Fibrosis-Related Diabetes in a Clinical Cystic Fibrosis Cohort.
  Katie L Kaput, Amber R Neece, Kelly L Stewart, Gregory J Stoddard, Victoria H Wang
  Endocrine Practice. 2026-08-01
• An Observational Cohort Study of Targeted Antibiotic Treatments of Cystic Fibrosis Exacerbations.
  HollyAnn R Jacobs, Kristyn A Packer, Luis G Vargas Buonfiglio, Zubin Bhakta, Andrew Ulrich
  Open Forum Infectious Diseases. 2026-01-01

Journal Articles

• Right-to-Left Ventricular End Diastolic Diameter Ratio in Severe Sepsis and Septic Shock  
  Theodore G Liou, Brent D Wilson, Nathan D Hatton, Partha Sardar, Promporn Suksaranjit, Meghan M Cirulis, ScienceDirect
• Genetic discovery, rigorous statistics, and pandemic influenza  
  Scholand MB, Liou TG, Chest, 1/1/2014
• Lung transplantation for chronic obstructive pulmonary disease  
  Liou TG, Raman SM, Cahill BC, Transplant Research and Risk Management, 7/3/2013

Books/Book Chapters

• Bronchial Asthma: A Guide for Practical Understanding and Treatment 
  Chapter: How the Pulmonary Function Laboratory Contributes to the Management of the Patient with Asthma 
  Kanner RE, Liou TGEditors: Gershhwin, M.E., Albertson,T..Humana Press, New York, New YorkEdition 5th,2006
• Bronchial Asthma: Principles of Diagnosis and Treatment; A Guide for Primary Care Physicians 
  Chapter: The role of the pulmonary function laboratory in patients with bronchial asthma 
  Kanner RE, Liou TGEditors: Gershhwin,M.E., Albertson,T..Humana Press, New York, New YorkEdition 4th,2002
• Rehabilitation of the Patient with Respiratory Disease, 
  Chapter: Impairment and Disability Evaluation 
  Liou TG, Kanner REEditors: Altose, M., Cherniack, N..McGraw-Hill, New York, New York1998

Abstracts/Posters

• Pulmonary vascular resistance in systemic sclerosis patients with pulmonary hypertension
  Hatton N, Frech T, Sawitzke A, Liou T, Markewitz B, CHEST, Honolulu, HI, 1/1/2011
• A mathematical model of biofilm formation
  Herald MC, Adler FR, Liou TG, North American Cystic Fibrosis Conference, Baltimore, MD, 1/1/2010
• The correlation of high mobility group box-1 protein, a pro-inflammatory biomarker, with clinical outcomes in CF
  Liou TG, Adler FR, Li Y, Sturrock A, Jensen J, Chen J, Clark T, Carveth H, Hoidal JR, Pediatric Pulmonology, North American Cystic Fibrosis Conference, Minneapolis, MN, 1/1/2009

Other

• Pulmonary function testing, Part I 
  Liou TG, Kanner RE, RT Magazine
  1/1/2005
• Pulmonary function testing, Part II 
  Liou TG, Kanner RE, RT Magazine
  1/1/2005
• American College of Physicians, PIER Project Module: Cystic Fibrosis 
  Shah A, Liou TG
  www.acponline.org
  1/1/2003